Cardiovascular magnetic resonance reveals myocardial involvement in patients with active stage of inflammatory bowel disease

Active inflammatory bowel disease (A-IBD) but not remission (R-IBD) has been associated with an increased risk of cardiovascular death and hospitalization for heart failure. Using cardiovascular magnetic resonance (CMR), this study aims to assess adverse myocardial remodeling in patients with IBD in...

Full description

Saved in:
Bibliographic Details
Published in:Clinical research in cardiology 2024-08
Main Authors: Fenski, Maximilian, Abazi, Endri, Gröschel, Jan, Hadler, Thomas, Kappelmayer, Diane, Kolligs, Frank, Prieto, Claudia, Botnar, Rene, Kunze, Karl-Philipp, Schulz-Menger, Jeanette
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c228t-a3d1d4fbd013c2369f80ae6269a041fcd8cb5737e682b8c75369d6387abd60c03
container_end_page
container_issue
container_start_page
container_title Clinical research in cardiology
container_volume
creator Fenski, Maximilian
Abazi, Endri
Gröschel, Jan
Hadler, Thomas
Kappelmayer, Diane
Kolligs, Frank
Prieto, Claudia
Botnar, Rene
Kunze, Karl-Philipp
Schulz-Menger, Jeanette
description Active inflammatory bowel disease (A-IBD) but not remission (R-IBD) has been associated with an increased risk of cardiovascular death and hospitalization for heart failure. Using cardiovascular magnetic resonance (CMR), this study aims to assess adverse myocardial remodeling in patients with IBD in correlation with disease activity. Forty-four IBD patients without cardiovascular disease (24 female, median-age: 39.5 years, 26 A-IBD, 18 R-IBD) and 44 matched healthy volunteers (HV) were prospectively enrolled. The disease stage was determined by endoscopic and patient-reported criteria. Participants underwent CMR for cardiac phenotyping: cine imaging and strain analysis were performed to assess ventricular function. T1 mapping, extracellular volume and late-gadolinium enhanced images were obtained to assess focal and diffuse myocardial fibrosis. Simultaneous T1 and T2 elevation (T1 > 1049.3 ms, T2 > 54 ms) was considered to indicate a myocardial segment was inflamed. 16/44 (16.4%) IBD patients described dyspnea on exertion and 10/44 (22.7%) reported chest pain. A-IBD patients showed impaired ventricular function, indicated by reduced global circumferential and radial strain despite preserved left-ventricular ejection fraction. 16% of all IBD patients had focal fibrosis in a non-ischemic pattern. A-IDB patients had increased markers of diffuse left ventricular fibrosis (T1-values: A-IBD: 1022.0 ± 34.83 ms, R-IBD: 1010.10 ± 32.88 ms, HV: 990.61 ± 29.35 ms, p 
doi_str_mv 10.1007/s00392-024-02503-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3088563678</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3088563678</sourcerecordid><originalsourceid>FETCH-LOGICAL-c228t-a3d1d4fbd013c2369f80ae6269a041fcd8cb5737e682b8c75369d6387abd60c03</originalsourceid><addsrcrecordid>eNo9kLtu3DAQRYkgRvzKD6QIWKaRMyQliiqDRV6AgTRJTYzIkcNAEjckV8YC_njTWcfFYG5x7i0OY-8E3AiA_mMGUINsQLb1OlBN94pdCKNFA3qQr1-yac_ZZc5_ADoBqn3DztUgQALABXvYYfIhbpjdYcbEF7xbqQTHE-W44uqopo1wznw5RvcE48zDusV5o4XWUjPfYwk1Zn4fym-OroSNeC54RzxOFZhmXBYsMR35GO9p5j5kwkzX7Gyqy_T2-V-xX18-_9x9a25_fP2--3TbOClNaVB54dtp9CCUk0oPkwEkLfWA0IrJeePGrlc9aSNH4_quIl4r0-PoNThQV-zDaXef4t8D5WKXkB3NM64UD9kqMKbTSvemovKEuhRzTjTZfQoLpqMVYJ-s25N1W63bf9ZtV0vvn_cP40L-pfJfs3oEgGaASQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3088563678</pqid></control><display><type>article</type><title>Cardiovascular magnetic resonance reveals myocardial involvement in patients with active stage of inflammatory bowel disease</title><source>Springer Nature</source><creator>Fenski, Maximilian ; Abazi, Endri ; Gröschel, Jan ; Hadler, Thomas ; Kappelmayer, Diane ; Kolligs, Frank ; Prieto, Claudia ; Botnar, Rene ; Kunze, Karl-Philipp ; Schulz-Menger, Jeanette</creator><creatorcontrib>Fenski, Maximilian ; Abazi, Endri ; Gröschel, Jan ; Hadler, Thomas ; Kappelmayer, Diane ; Kolligs, Frank ; Prieto, Claudia ; Botnar, Rene ; Kunze, Karl-Philipp ; Schulz-Menger, Jeanette</creatorcontrib><description>Active inflammatory bowel disease (A-IBD) but not remission (R-IBD) has been associated with an increased risk of cardiovascular death and hospitalization for heart failure. Using cardiovascular magnetic resonance (CMR), this study aims to assess adverse myocardial remodeling in patients with IBD in correlation with disease activity. Forty-four IBD patients without cardiovascular disease (24 female, median-age: 39.5 years, 26 A-IBD, 18 R-IBD) and 44 matched healthy volunteers (HV) were prospectively enrolled. The disease stage was determined by endoscopic and patient-reported criteria. Participants underwent CMR for cardiac phenotyping: cine imaging and strain analysis were performed to assess ventricular function. T1 mapping, extracellular volume and late-gadolinium enhanced images were obtained to assess focal and diffuse myocardial fibrosis. Simultaneous T1 and T2 elevation (T1 &gt; 1049.3 ms, T2 &gt; 54 ms) was considered to indicate a myocardial segment was inflamed. 16/44 (16.4%) IBD patients described dyspnea on exertion and 10/44 (22.7%) reported chest pain. A-IBD patients showed impaired ventricular function, indicated by reduced global circumferential and radial strain despite preserved left-ventricular ejection fraction. 16% of all IBD patients had focal fibrosis in a non-ischemic pattern. A-IDB patients had increased markers of diffuse left ventricular fibrosis (T1-values: A-IBD: 1022.0 ± 34.83 ms, R-IBD: 1010.10 ± 32.88 ms, HV: 990.61 ± 29.35 ms, p &lt; .01). Significantly more participants with A-IDB (8/26, 30.8%) had at least one inflamed myocardial segment than patients in remission (0/18) and HV (1/44, 2.3%, p &lt; .01). Markers of diffuse fibrosis correlated with disease activity. This study, using CMR, provides evidence of myocardial involvement and patterns of adverse left ventricular remodeling in patients with IBD. ISRCTN30941346.</description><identifier>ISSN: 1861-0684</identifier><identifier>ISSN: 1861-0692</identifier><identifier>EISSN: 1861-0692</identifier><identifier>DOI: 10.1007/s00392-024-02503-5</identifier><identifier>PMID: 39102000</identifier><language>eng</language><publisher>Germany</publisher><ispartof>Clinical research in cardiology, 2024-08</ispartof><rights>2024. The Author(s).</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c228t-a3d1d4fbd013c2369f80ae6269a041fcd8cb5737e682b8c75369d6387abd60c03</cites><orcidid>0000-0003-3100-1092</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39102000$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fenski, Maximilian</creatorcontrib><creatorcontrib>Abazi, Endri</creatorcontrib><creatorcontrib>Gröschel, Jan</creatorcontrib><creatorcontrib>Hadler, Thomas</creatorcontrib><creatorcontrib>Kappelmayer, Diane</creatorcontrib><creatorcontrib>Kolligs, Frank</creatorcontrib><creatorcontrib>Prieto, Claudia</creatorcontrib><creatorcontrib>Botnar, Rene</creatorcontrib><creatorcontrib>Kunze, Karl-Philipp</creatorcontrib><creatorcontrib>Schulz-Menger, Jeanette</creatorcontrib><title>Cardiovascular magnetic resonance reveals myocardial involvement in patients with active stage of inflammatory bowel disease</title><title>Clinical research in cardiology</title><addtitle>Clin Res Cardiol</addtitle><description>Active inflammatory bowel disease (A-IBD) but not remission (R-IBD) has been associated with an increased risk of cardiovascular death and hospitalization for heart failure. Using cardiovascular magnetic resonance (CMR), this study aims to assess adverse myocardial remodeling in patients with IBD in correlation with disease activity. Forty-four IBD patients without cardiovascular disease (24 female, median-age: 39.5 years, 26 A-IBD, 18 R-IBD) and 44 matched healthy volunteers (HV) were prospectively enrolled. The disease stage was determined by endoscopic and patient-reported criteria. Participants underwent CMR for cardiac phenotyping: cine imaging and strain analysis were performed to assess ventricular function. T1 mapping, extracellular volume and late-gadolinium enhanced images were obtained to assess focal and diffuse myocardial fibrosis. Simultaneous T1 and T2 elevation (T1 &gt; 1049.3 ms, T2 &gt; 54 ms) was considered to indicate a myocardial segment was inflamed. 16/44 (16.4%) IBD patients described dyspnea on exertion and 10/44 (22.7%) reported chest pain. A-IBD patients showed impaired ventricular function, indicated by reduced global circumferential and radial strain despite preserved left-ventricular ejection fraction. 16% of all IBD patients had focal fibrosis in a non-ischemic pattern. A-IDB patients had increased markers of diffuse left ventricular fibrosis (T1-values: A-IBD: 1022.0 ± 34.83 ms, R-IBD: 1010.10 ± 32.88 ms, HV: 990.61 ± 29.35 ms, p &lt; .01). Significantly more participants with A-IDB (8/26, 30.8%) had at least one inflamed myocardial segment than patients in remission (0/18) and HV (1/44, 2.3%, p &lt; .01). Markers of diffuse fibrosis correlated with disease activity. This study, using CMR, provides evidence of myocardial involvement and patterns of adverse left ventricular remodeling in patients with IBD. ISRCTN30941346.</description><issn>1861-0684</issn><issn>1861-0692</issn><issn>1861-0692</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kLtu3DAQRYkgRvzKD6QIWKaRMyQliiqDRV6AgTRJTYzIkcNAEjckV8YC_njTWcfFYG5x7i0OY-8E3AiA_mMGUINsQLb1OlBN94pdCKNFA3qQr1-yac_ZZc5_ADoBqn3DztUgQALABXvYYfIhbpjdYcbEF7xbqQTHE-W44uqopo1wznw5RvcE48zDusV5o4XWUjPfYwk1Zn4fym-OroSNeC54RzxOFZhmXBYsMR35GO9p5j5kwkzX7Gyqy_T2-V-xX18-_9x9a25_fP2--3TbOClNaVB54dtp9CCUk0oPkwEkLfWA0IrJeePGrlc9aSNH4_quIl4r0-PoNThQV-zDaXef4t8D5WKXkB3NM64UD9kqMKbTSvemovKEuhRzTjTZfQoLpqMVYJ-s25N1W63bf9ZtV0vvn_cP40L-pfJfs3oEgGaASQ</recordid><startdate>20240805</startdate><enddate>20240805</enddate><creator>Fenski, Maximilian</creator><creator>Abazi, Endri</creator><creator>Gröschel, Jan</creator><creator>Hadler, Thomas</creator><creator>Kappelmayer, Diane</creator><creator>Kolligs, Frank</creator><creator>Prieto, Claudia</creator><creator>Botnar, Rene</creator><creator>Kunze, Karl-Philipp</creator><creator>Schulz-Menger, Jeanette</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3100-1092</orcidid></search><sort><creationdate>20240805</creationdate><title>Cardiovascular magnetic resonance reveals myocardial involvement in patients with active stage of inflammatory bowel disease</title><author>Fenski, Maximilian ; Abazi, Endri ; Gröschel, Jan ; Hadler, Thomas ; Kappelmayer, Diane ; Kolligs, Frank ; Prieto, Claudia ; Botnar, Rene ; Kunze, Karl-Philipp ; Schulz-Menger, Jeanette</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c228t-a3d1d4fbd013c2369f80ae6269a041fcd8cb5737e682b8c75369d6387abd60c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fenski, Maximilian</creatorcontrib><creatorcontrib>Abazi, Endri</creatorcontrib><creatorcontrib>Gröschel, Jan</creatorcontrib><creatorcontrib>Hadler, Thomas</creatorcontrib><creatorcontrib>Kappelmayer, Diane</creatorcontrib><creatorcontrib>Kolligs, Frank</creatorcontrib><creatorcontrib>Prieto, Claudia</creatorcontrib><creatorcontrib>Botnar, Rene</creatorcontrib><creatorcontrib>Kunze, Karl-Philipp</creatorcontrib><creatorcontrib>Schulz-Menger, Jeanette</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical research in cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fenski, Maximilian</au><au>Abazi, Endri</au><au>Gröschel, Jan</au><au>Hadler, Thomas</au><au>Kappelmayer, Diane</au><au>Kolligs, Frank</au><au>Prieto, Claudia</au><au>Botnar, Rene</au><au>Kunze, Karl-Philipp</au><au>Schulz-Menger, Jeanette</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiovascular magnetic resonance reveals myocardial involvement in patients with active stage of inflammatory bowel disease</atitle><jtitle>Clinical research in cardiology</jtitle><addtitle>Clin Res Cardiol</addtitle><date>2024-08-05</date><risdate>2024</risdate><issn>1861-0684</issn><issn>1861-0692</issn><eissn>1861-0692</eissn><abstract>Active inflammatory bowel disease (A-IBD) but not remission (R-IBD) has been associated with an increased risk of cardiovascular death and hospitalization for heart failure. Using cardiovascular magnetic resonance (CMR), this study aims to assess adverse myocardial remodeling in patients with IBD in correlation with disease activity. Forty-four IBD patients without cardiovascular disease (24 female, median-age: 39.5 years, 26 A-IBD, 18 R-IBD) and 44 matched healthy volunteers (HV) were prospectively enrolled. The disease stage was determined by endoscopic and patient-reported criteria. Participants underwent CMR for cardiac phenotyping: cine imaging and strain analysis were performed to assess ventricular function. T1 mapping, extracellular volume and late-gadolinium enhanced images were obtained to assess focal and diffuse myocardial fibrosis. Simultaneous T1 and T2 elevation (T1 &gt; 1049.3 ms, T2 &gt; 54 ms) was considered to indicate a myocardial segment was inflamed. 16/44 (16.4%) IBD patients described dyspnea on exertion and 10/44 (22.7%) reported chest pain. A-IBD patients showed impaired ventricular function, indicated by reduced global circumferential and radial strain despite preserved left-ventricular ejection fraction. 16% of all IBD patients had focal fibrosis in a non-ischemic pattern. A-IDB patients had increased markers of diffuse left ventricular fibrosis (T1-values: A-IBD: 1022.0 ± 34.83 ms, R-IBD: 1010.10 ± 32.88 ms, HV: 990.61 ± 29.35 ms, p &lt; .01). Significantly more participants with A-IDB (8/26, 30.8%) had at least one inflamed myocardial segment than patients in remission (0/18) and HV (1/44, 2.3%, p &lt; .01). Markers of diffuse fibrosis correlated with disease activity. This study, using CMR, provides evidence of myocardial involvement and patterns of adverse left ventricular remodeling in patients with IBD. ISRCTN30941346.</abstract><cop>Germany</cop><pmid>39102000</pmid><doi>10.1007/s00392-024-02503-5</doi><orcidid>https://orcid.org/0000-0003-3100-1092</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1861-0684
ispartof Clinical research in cardiology, 2024-08
issn 1861-0684
1861-0692
1861-0692
language eng
recordid cdi_proquest_miscellaneous_3088563678
source Springer Nature
title Cardiovascular magnetic resonance reveals myocardial involvement in patients with active stage of inflammatory bowel disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T23%3A28%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiovascular%20magnetic%20resonance%20reveals%20myocardial%20involvement%20in%20patients%20with%20active%20stage%20of%20inflammatory%20bowel%20disease&rft.jtitle=Clinical%20research%20in%20cardiology&rft.au=Fenski,%20Maximilian&rft.date=2024-08-05&rft.issn=1861-0684&rft.eissn=1861-0692&rft_id=info:doi/10.1007/s00392-024-02503-5&rft_dat=%3Cproquest_cross%3E3088563678%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c228t-a3d1d4fbd013c2369f80ae6269a041fcd8cb5737e682b8c75369d6387abd60c03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3088563678&rft_id=info:pmid/39102000&rfr_iscdi=true